Abstract
As China faces demographic shifts and socioeconomic changes, the burden of Alzheimer’s disease (AD) and associated cognitive impairments is increasing dramatically, with significant implications for public health and the economy. This systematic review and meta-analysis aims to provide a comprehensive assessment of the prevalence and incidence of AD across China. Drawing from an extensive search of international and Chinese databases up to August 27, 2023, including PubMed, Embase, and the Cochrane Library, we synthesized data from 105 studies. Our analysis reveals a combined prevalence of AD of 3.48% within a sample of 626,276 elderly individuals and an incidence rate of 7.90 per 1000 person-years. Subgroup and meta-regression analyses highlight age and gender as pivotal factors influencing these epidemiological patterns. Notably, significant heterogeneity exists due to variations in diagnostic criteria and study quality, impacting the comparability of findings. This meta-analysis underscores the need for continued research into demographic and modifiable risk factors influencing AD, while emphasizing standardized reporting practices to address these limitations and improve the understanding of AD’s challenge in China.
Similar content being viewed by others
References
Breijyeh Z, Karaman R. Comprehensive review on alzheimer’s disease: causes and treatment. Molecules (Basel, Switzerland). 2020;25(24):5789. https://doi.org/10.3390/molecules25245789.
Lambert MA, Bickel H, Prince M, Fratiglioni L, Von Strauss E, Frydecka D, et al. Estimating the burden of early onset dementia; systematic review of disease prevalence. Eur J Neurol. 2014;21(4):563–9. https://doi.org/10.1111/ene.12325.
Dubois B, Feldman HH, Jacova C, Hampel H, Molinuevo JL, Blennow K, et al. Advancing research diagnostic criteria for Alzheimer’s disease: the IWG-2 criteria. Lancet Neurol. 2014;13(6):614–29. https://doi.org/10.1016/S1474-4422(14)70090-0.
Livingston G, Sommerlad A, Orgeta V, Costafreda SG, Huntley J, Ames D, et al. Dementia prevention, intervention, and care. Lancet (London, England). 2017;390(10113):2673–734. https://doi.org/10.1016/S0140-6736(17)31363-6.
Wang Q-H, Wang X, Bu X-L, Lian Y, Xiang Y, Luo H-B, et al. Comorbidity burden of dementia: a hospital-based retrospective study from 2003 to 2012 in seven cities in China. Neurosci Bull. 2017;33(6):703–10. https://doi.org/10.1007/s12264-017-0193-3.
Li C, Götz J. Tau-based therapies in neurodegeneration: opportunities and challenges. Nat Rev Drug Discovery. 2017;16(12):863–83. https://doi.org/10.1038/nrd.2017.155.
Stevenson-Hoare J, Heslegrave A, Leonenko G, Fathalla D, Bellou E, Luckcuck L, et al. Plasma biomarkers and genetics in the diagnosis and prediction of Alzheimer’s disease. Brain A J Neurol. 2023;146(2):690–9. https://doi.org/10.1093/brain/awac128.
Hox J, Moerbeek M, Van de Schoot R. Multilevel analysis: techniques and applications. London: Routledge; 2017.
Viechtbauer W. Conducting meta-analyses in R with the metafor package. J Stat Softw. 2010;36:1–48. https://doi.org/10.18637/jss.v036.i03.
Fowkes FGR, Rudan D, Rudan I, Aboyans V, Denenberg JO, McDermott MM, et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. The Lancet. 2013;382(9901):1329–40. https://doi.org/10.1016/S0140-6736(13)61249-0.
Fanelli D, Costas R, Ioannidis JPA. Meta-assessment of bias in science. Proc Natl Acad Sci USA. 2017;114(14):3714–9. https://doi.org/10.1073/pnas.1618569114.
Hubble JP, Busenbark KL, Pahwa R, Lyons K, Koller WC. Clinical expression of essential tremor: effects of gender and age. Mov Disord. 1997;12(6):969–72. https://doi.org/10.1002/mds.870120620.
Baranyi G, Scholl C, Fazel S, Patel V, Priebe S, Mundt AP. Severe mental illness and substance use disorders in prisoners in low-income and middle-income countries: a systematic review and meta-analysis of prevalence studies. Lancet Glob Health. 2019;7(4):e461–71. https://doi.org/10.1016/S2214-109X(18)30539-4.
Jia J, Zuo X, Jia X-F, et al. Diagnosis and treatment of dementia in neurology outpatient departments of general hospitals in China. Alzheimer’s Dement. 2016;12(4):446–53. https://doi.org/10.1016/j.jalz.2015.06.1892].
Sun F. Caregiving stress and coping: a thematic analysis of Chinese family caregivers of persons with dementia. Dementia (London, England). 2014;13(6):803–18. https://doi.org/10.1177/1471301213485593.
Wu C, Gao L, Chen S, Dong H. Care services for elderly people with dementia in rural China: a case study. Bull World Health Organ. 2016;94(3):167–73. https://doi.org/10.2471/BLT.15.160929.
Yuan J, Zhang Z, Wen H, et al. Incidence of dementia and subtypes: a cohort study in four regions in China. Alzheimers Dement. 2016;12(3):262–71.
Meng H, Li Y, Zhang W, Zhao Y, Niu X, Guo J. The relationship between cognitive impairment and homocysteine in a B12 and folate deficient population in China: a cross-sectional study. Medicine. 2019;98(47):e17970. https://doi.org/10.1097/md.0000000000017970.
Yingquan W, Jinghong L, Ruixia J, Yong X. Prediction of the prevalence of Alzheimer’s disease in China from 2020 to 2050. Alzheimer’s Dis Relat Dis. 2019;2(1):289–98. https://doi.org/10.3969/j.issn.2096-5516.2019.01.012.
Prince M, Wimo A, Guerchet M, Ali G-C, Wu Y-T, Prina M. World Alzheimer report 2015. The global impact of dementia: an analysis of prevalence, incidence, cost and trends.Alzheimer’s disease international. 2015.World Alzheimer Report 2015 | Alzheimer’s Disease International (ADI) (alzint.org).Accessed August 2015.
Jansen WJ, Ossenkoppele R, Knol DL, Tijms BM, Scheltens P, Verhey FRJ, et al. Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis. JAMA. 2015;313(19):1924–38. https://doi.org/10.1001/jama.2015.4668.
Parnetti L, Chipi E, Salvadori N, D’Andrea K, Eusebi P. Prevalence and risk of progression of preclinical Alzheimer’s disease stages: a systematic review and meta-analysis. Alzheimer’s Res Ther. 2019;11(1):7. https://doi.org/10.1186/s13195-018-0459-7.
Hendriks S, Peetoom K, Bakker C, van der Flier WM, Papma JM, Koopmans R, et al. Global prevalence of young-onset dementia: a systematic review and meta-analysis. JAMA Neurol. 2021;78(9):1080–90. https://doi.org/10.1001/jamaneurol.2021.2161.
Cao Q, Tan C-C, Xu W, Hu H, Cao X-P, Dong Q, et al. The prevalence of dementia: a systematic review and meta-analysis. J Alzheimer’s Dis. 2020;73(3):1157–66. https://doi.org/10.3233/JAD-191092.
Bacigalupo I, Mayer F, Lacorte E, Di Pucchio A, Marzolini F, Canevelli M, et al. A systematic review and meta-analysis on the prevalence of dementia in Europe: estimates from the highest-quality studies adopting the DSM IV diagnostic criteria. J Alzheimer’s Dis. 2018;66(4):1471–81. https://doi.org/10.3233/JAD-180416.
Ossenkoppele R, Jansen WJ, Rabinovici GD, Knol DL, van der Flier WM, van Berckel BNM, et al. Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis. JAMA. 2015;313(19):1939–49. https://doi.org/10.1001/jama.2015.4669.
Petersen RC, Lopez O, Armstrong MJ, Getchius TSD, Ganguli M, Gloss D, et al. Practice guideline update summary: Mild cognitive impairment: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Neurology. 2018;90(3):126–35. https://doi.org/10.1212/WNL.0000000000004826.
Gustavsson A, Norton N, Fast T, Frölich L, Georges J, Holzapfel D, et al. Global estimates on the number of persons across the Alzheimer’s disease continuum. Alzheimers Dement. 2023;19(2):658–70. https://doi.org/10.1002/alz.12694.
Chêne G, Beiser A, Au R, et al. Gender and incidence of dementia in the Framingham Heart Study from mid-adult life. Alzheimer’s Dement. 2015;11(3):310. https://doi.org/10.1016/j.jalz.2013.10.005.
Scourfield P. Unaging. the four factors that impact how you age Robert P. Friedland, Cambridge University Press, Cambridge, UK, 2022, 344 pp., pbk £14.99, ISBN 13: 978-1-00-908774-2. Ageing Soc. 2023;43(10):2472–3. https://doi.org/10.1017/S0144686X23000375.
Ren R, Qi J, Lin S, et al. The China Alzheimer Report 2022. General Psychiatry. 2022;35(1):e100751. https://doi.org/10.1136/gpsych-2022-100751.
Yang JJ, Yu D, Wen W, et al. Tobacco smoking and mortality in Asia: a pooled meta-analysis. JAMA Netw Open. 2019;2(3):e191474. https://doi.org/10.1001/jamanetworkopen.2019.1474.
Livingston G, Huntley J, Sommerlad A, et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet (London, England). 2020;396(10248):413–46. https://doi.org/10.1016/S0140-6736(20)30367-6.
Funding
The authors have not disclosed any funding.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors have not disclosed any competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Ji, Q., Chen, J., Li, Y. et al. Incidence and prevalence of Alzheimer’s disease in China: a systematic review and meta-analysis. Eur J Epidemiol 39, 701–714 (2024). https://doi.org/10.1007/s10654-024-01144-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10654-024-01144-2